Latest Articles
Bayer Starts New Phase III Study with Mirena® for the Treatment of Nonatypical Endometrial Hyperplasia - Business Wire
Bayer Starts New Phase III Study with Mirena® for the Treatment of Nonatypical Endometrial Hyperplasia Business Wire
Published: Dec. 2, 2025, 1:05 p.m.
Bayer (BAYRY) starts SUNFLOWER Phase III Mirena trial for nonatypical endometrial hyperplasia - Stock Titan
Bayer (BAYRY) starts SUNFLOWER Phase III Mirena trial for nonatypical endometrial hyperplasia Stock Titan
Published: Dec. 2, 2025, 1:05 p.m.
Bayer starts phase III study with Mirena for treatment of nonatypical endometrial hyperplasia - MarketScreener
Bayer starts phase III study with Mirena for treatment of nonatypical endometrial hyperplasia MarketScreener
Published: Dec. 2, 2025, 7:36 a.m.
Bayer starts new phase III study with Mirena for the treatment of nonatypical endometrial hyperplasia - MarketScreener
Bayer starts new phase III study with Mirena for the treatment of nonatypical endometrial hyperplasia MarketScreener
Published: Dec. 2, 2025, 7:36 a.m.
Bayer starts Phase III study with long-acting reversible intrauterine system for treatment of nonatypical endometrial hyperplasia - Bayer
Bayer starts Phase III study with long-acting reversible intrauterine system for treatment of nonatypical endometrial hyperplasia Bayer
Published: Dec. 2, 2025, 7:30 a.m.
Bayer begins Phase III study with Mirena for nonatypical endometrial hyperplasia - Medical Dialogues
Bayer begins Phase III study with Mirena for nonatypical endometrial hyperplasia Medical Dialogues
Published: Dec. 2, 2025, 5 a.m.
Gene Polymorphisms Determining Sex Hormone-Binding Globulin Levels and Endometriosis Risk.
Endometriosis is a hormone-dependent disease, in the pathophysiology of which sex hormones (androgens, estrogens, etc.) are involved. The level of bioactive androgens/estrogens (in the free state) in the organism largely …
Published: Nov. 30, 2025, midnight
A Risk-Stratified Model for Predicting Endometrial Atypical Hyperplasia and Cancer to Guide Biopsy Decisions in Asymptomatic Postmenopausal Women - Frontiers
A Risk-Stratified Model for Predicting Endometrial Atypical Hyperplasia and Cancer to Guide Biopsy Decisions in Asymptomatic Postmenopausal Women Frontiers
Published: Nov. 24, 2025, 8:22 p.m.
New Zealand Policy Shift: Ban on New Puberty Blockers for Transgender Youth - Batam News Asia
New Zealand Policy Shift: Ban on New Puberty Blockers for Transgender Youth Batam News Asia
Published: Nov. 20, 2025, 10:21 a.m.
Australia to open 11 endometriosis, pelvic pain clinics - Healthcare Asia Magazine
Australia to open 11 endometriosis, pelvic pain clinics Healthcare Asia Magazine
Published: Nov. 17, 2025, 2:58 a.m.
Link copied to clipboard!